Eversept Partners, LP Zai Lab LTD Transaction History

Eversept Partners, LP

  • $1.32 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Nov 08, 2023
SELL
$25.3 - $39.67 $2.96 Million - $4.63 Million
-116,823 Reduced 67.92%
55,176 $1.53 Million
Q2 2023

Aug 14, 2023
SELL
$25.3 - $39.67 $2.96 Million - $4.63 Million
-116,823 Reduced 67.92%
55,176 $1.53 Million
Q1 2023

Nov 08, 2023
BUY
$30.21 - $48.1 $3.53 Million - $5.62 Million
116,823 Added 211.73%
171,999 $5.72 Million
Q1 2023

May 15, 2023
BUY
$30.21 - $48.1 $5.2 Million - $8.27 Million
171,999 New
171,999 $5.72 Million

Others Institutions Holding ZLAB

# of Institutions
116
Shares Held
40.8M
Call Options Held
63.1K
Put Options Held
420K
View Full List

About Zai Lab Ltd

ZLAB Quotes by TradingView
  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email